Rare
lephants
Screener
Toggle theme
Co-Diagnostics, Inc.
CODX
·
Healthcare, Medical Devices, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2022
FY2021
FY2020
Total Cash from Operations:
$65.1M
Line Item
Value
% of Total
Capital Expenditures
$774.4K
1.2%
Other Investing
$5.0M
7.8%
Working Capital
$17.2M
26.4%
Net Cash Flow
$42.1M
64.6%
Download CSV
